Medical 21, Inc. Announces Approval to Begin Human Clinical Studies in Spain
Medical 21, Inc. , a medical technology company focused on reshaping the future of cardiac bypass surgery, announced today that the Company has received approval to begin human clinical studies on the MAVERICS graft in Spain.